The Future of Fluid Biomarkers for Alzheimer’s Disease and Related Dementias

The field of biomarkers is constantly evolving, leading to developments in diagnosing and treating different kinds of dementia, but what exactly are biomarkers and how has our understanding of these measures changed over time?  Dr. Henrik Zetterberg joins Dementia Matters to talk about the latest updates in research on fluid biomarkers. Dr. Zetterberg goes in depth on the role and properties of different biomarkers and how new measures and tools, like blood tests, are impacting diagnostic tests for Alzheimer’s and other neurodegenerative diseases. Guest: Henrik Zetterberg, MD, PhD, professor of neurochemistry, University of Gothenburg, University College London, visiting professor, University of Wisconsin–Madison, Biomarker Core co-leader, Wisconsin Alzheimer’s Disease Research Center Show Notes Learn more about Dr. Zetterberg on his University College London and University of Gothenburg profiles. Learn more about blood tests in our episode with Dr. Thomas Karikari, “Update on Blood Tests for Alzheimer’s Disease,” on our website. Learn more about the different biomarker procedures, such as lumbar punctures, through the Biomarker Videos on our website. Connect with us Find transcripts and more at our website. Email Dementia Matters: [email protected] Follow us on Facebook and Twitter. Subscribe to the Wisconsin Alzheimer’s Disease Research Center’s e-newsletter. Enjoy Dementia Matters? Consider making a gift to the Dementia Matters fund through the UW Initiative to End Alzheimer’s. All donations go toward outreach and production.

There are no comments yet.

Please log in to write the first comment.